SNORA13

Across TCGA pan-cancer cohorts, SNORA13 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated SNORA13 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher SNORA13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORA13 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCEC show a favorable association.

THCA, ACC, and LUAD are the cancer types where SNORA13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	II,III,IV	0.504	0.858	<.001	99	view →
ACC	OS	Median	All	0.380	0.820	<.001	85	view →
LUAD	OS	Tertile	II,III,IV	0.610	0.831	.009	59	view →
STAD	DFS	Tertile	IV	0.199	0.651	.010	46	view →
KICH	DFS	Tertile	II,III,IV	0.549	1.000	.003	24	view →
COAD	OS	Tertile	II,III,IV	0.485	0.812	<.001	21	view →
SKCM	OS	Quartile	All	0.843	0.693	.002	20	view →
UVM	DFS	Quartile	III,IV	0.208	0.772	.007	18	view →
UCEC	OS	Median	II,III,IV	0.733	0.418	.024	18	view →
PRAD	DFS	Median	All	0.695	0.885	<.001	18	view →
ESCA	DFS	Tertile	II,III,IV	0.335	0.566	.008	18	view →
BLCA	OS	Quartile	II,III,IV	0.723	0.535	.008	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

SNORA13–THCA (DFS)

Open the THCA breakdown →